Discovery of NMDA Glycine Site Inhibitors from the Chemical Universe Database GDB
暂无分享,去创建一个
[1] R. Dingledine,et al. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. , 1988, Science.
[2] J. Monahan,et al. d-Cycloserine: A ligand for the N-methyl-d-aspartate coupled glycine receptor has partial agonist characteristics , 1989, Neuroscience Letters.
[3] D. Choi,et al. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. , 1990, Annual review of neuroscience.
[4] P. Ascher,et al. Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N‐methyl‐D‐aspartate receptor. , 1990, The Journal of physiology.
[5] J. Olney,et al. Excitotoxic amino acids and neuropsychiatric disorders. , 1990, Annual review of pharmacology and toxicology.
[6] G. B. Watson,et al. Pharmacological characteristics of cyclic homologues of glycine at the N-methyl-d-aspartate receptor-associated glycine site , 1990, Neuropharmacology.
[7] J. Olney,et al. NMDA antagonist neurotoxicity: mechanism and prevention. , 1991, Science.
[8] S. Urwyler,et al. Biochemical and thermodynamic aspects of the binding of [3H]glycine to its strychnine-insensitive recognition site associated with the N-methyl-D-aspartate receptor complex. , 1992, Biochemical pharmacology.
[9] J. Gasteiger,et al. FROM ATOMS AND BONDS TO THREE-DIMENSIONAL ATOMIC COORDINATES : AUTOMATIC MODEL BUILDERS , 1993 .
[10] P. Wood. The co-agonist concept: is the NMDA-associated glycine receptor saturated in vivo? , 1995, Life sciences.
[11] T. Smart. Regulation of excitatory and inhibitory neurotransmitter-gated ion channels by protein phosphorylation , 1997, Current Opinion in Neurobiology.
[12] David S. Goodsell,et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .
[13] J. Kemp,et al. NMDA receptor pathways as drug targets , 2002, Nature Neuroscience.
[14] Hans-Joachim Böhm,et al. A guide to drug discovery: Hit and lead generation: beyond high-throughput screening , 2003, Nature Reviews Drug Discovery.
[15] R. Didziapetris,et al. Fragmental methods in the analysis of biological activities of diverse compound sets. , 2003, Mini reviews in medicinal chemistry.
[16] Eric Gouaux,et al. Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand‐binding core , 2003, The EMBO journal.
[17] Andreas Bender,et al. Molecular Similarity Searching Using Atom Environments, Information-Based Feature Selection, and a Naïve Bayesian Classifier , 2004, J. Chem. Inf. Model..
[18] J. Reymond,et al. Synthesis and esterolytic activity of catalytic peptide dendrimers. , 2004, Chemistry.
[19] P. Willett,et al. Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures. , 2004, Organic & biomolecular chemistry.
[20] Jean-Louis Reymond,et al. Virtual exploration of the small-molecule chemical universe below 160 Daltons. , 2005, Angewandte Chemie.
[21] Pedro Alexandrino Fernandes,et al. Protein–ligand docking: Current status and future challenges , 2006, Proteins.
[22] C. E. Peishoff,et al. A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.
[23] P. Hawkins,et al. Comparison of shape-matching and docking as virtual screening tools. , 2007, Journal of medicinal chemistry.
[24] Jean-Louis Reymond,et al. Virtual Exploration of the Chemical Universe up to 11 Atoms of C, N, O, F: Assembly of 26.4 Million Structures (110.9 Million Stereoisomers) and Analysis for New Ring Systems, Stereochemistry, Physicochemical Properties, Compound Classes, and Drug Discovery , 2007, J. Chem. Inf. Model..
[25] N. Franks. General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal , 2008, Nature Reviews Neuroscience.
[26] Christopher R. Corbeil,et al. Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go , 2008, British journal of pharmacology.